Pharmaceutical Industry India
-
Finance & Investment
Supriya Lifescience Ltd. Reports Rs 145.07 Cr Revenue and 35.6% EBITDA Margin in Q1 FY26
New Delhi | 20, August 2025 : Supriya Lifescience Ltd., a global API manufacturer with operations in over 86 countries,…
Read More » -
Trending
How India Can Lead the Global Shift in API Self-Reliance Amid Tariff Pressures
In recent years, the global pharmaceutical landscape has witnessed growing momentum toward self-reliance in Active Pharmaceutical Ingredient (API) manufacturing, particularly…
Read More »
